Cargando…

Reducing hyperglycaemia post-kidney and liver transplant: a quality improvement initiative

BACKGROUND: In-hospital glycaemic management can reduce post-transplant morbidity, but is not always part of transplant care. OBJECTIVE: We aimed to reduce the mean number of postoperative days in hyperglycaemia (≥2 blood glucose >12 mmol/L in 24 hours) in kidney and liver transplant recipients b...

Descripción completa

Detalles Bibliográficos
Autores principales: Clemens, Kristin K, Brahmania, Mayur, Weernink, Corrine, Lofty, Khaled, Rjoob, Hani, Berberich, Amanda, Gob, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115008/
https://www.ncbi.nlm.nih.gov/pubmed/35577401
http://dx.doi.org/10.1136/bmjoq-2021-001796
_version_ 1784709890914123776
author Clemens, Kristin K
Brahmania, Mayur
Weernink, Corrine
Lofty, Khaled
Rjoob, Hani
Berberich, Amanda
Gob, Alan
author_facet Clemens, Kristin K
Brahmania, Mayur
Weernink, Corrine
Lofty, Khaled
Rjoob, Hani
Berberich, Amanda
Gob, Alan
author_sort Clemens, Kristin K
collection PubMed
description BACKGROUND: In-hospital glycaemic management can reduce post-transplant morbidity, but is not always part of transplant care. OBJECTIVE: We aimed to reduce the mean number of postoperative days in hyperglycaemia (≥2 blood glucose >12 mmol/L in 24 hours) in kidney and liver transplant recipients by 30%. We also aimed to reduce the mean number of days between transplant admission to endocrine consult by 2.0 days. DESIGN, SETTING, PARTICIPANTS: We conducted a quality improvement project in liver and kidney transplant recipients admitted to an academic transplant unit in Canada between 1 March 2019 and 1 May 2021. INTERVENTION: We developed a bedside algorithm to monitor post-transplant capillary blood glucose; the algorithm also included thresholds for nursing-initiated inpatient endocrinology consultation. MAIN OUTCOME AND MEASURES: We examined outcome (postoperative days in hyperglycaemia, days to inpatient endocrine consultation), process (nursing documentation of postoperative blood sugars) and balancing measures (nursing workload, postoperative days in hypoglycaemia) following implementation of our algorithm. We used Plan-Do-See-Act cycles to study three iterations of our algorithm, and used box plots to present outcomes before and after algorithm implementation. RESULTS: In the pre-intervention period, 21 transplant recipients spent a mean of 4.1 (SD 2.4) postoperative days in hyperglycaemia before endocrine consultation. The mean number of days between hospital admission to endocrine consult was 10.7 (SD 13.0) days. In the post-intervention period, we observed a 62% reduction in postoperative days in hyperglycaemia. The mean number of days between admission and endocrine consult was reduced by 6.3 days (59% reduction). CONCLUSIONS: Implementation of a simple, bedside algorithm for postoperative glucose monitoring and detection of hyperglycaemia in transplant patients, reduced the mean number of postoperative days in hyperglycaemia and time to inpatient endocrine consultation. Our algorithm continues to be used in our academic transplant unit.
format Online
Article
Text
id pubmed-9115008
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-91150082022-06-04 Reducing hyperglycaemia post-kidney and liver transplant: a quality improvement initiative Clemens, Kristin K Brahmania, Mayur Weernink, Corrine Lofty, Khaled Rjoob, Hani Berberich, Amanda Gob, Alan BMJ Open Qual Quality Improvement Report BACKGROUND: In-hospital glycaemic management can reduce post-transplant morbidity, but is not always part of transplant care. OBJECTIVE: We aimed to reduce the mean number of postoperative days in hyperglycaemia (≥2 blood glucose >12 mmol/L in 24 hours) in kidney and liver transplant recipients by 30%. We also aimed to reduce the mean number of days between transplant admission to endocrine consult by 2.0 days. DESIGN, SETTING, PARTICIPANTS: We conducted a quality improvement project in liver and kidney transplant recipients admitted to an academic transplant unit in Canada between 1 March 2019 and 1 May 2021. INTERVENTION: We developed a bedside algorithm to monitor post-transplant capillary blood glucose; the algorithm also included thresholds for nursing-initiated inpatient endocrinology consultation. MAIN OUTCOME AND MEASURES: We examined outcome (postoperative days in hyperglycaemia, days to inpatient endocrine consultation), process (nursing documentation of postoperative blood sugars) and balancing measures (nursing workload, postoperative days in hypoglycaemia) following implementation of our algorithm. We used Plan-Do-See-Act cycles to study three iterations of our algorithm, and used box plots to present outcomes before and after algorithm implementation. RESULTS: In the pre-intervention period, 21 transplant recipients spent a mean of 4.1 (SD 2.4) postoperative days in hyperglycaemia before endocrine consultation. The mean number of days between hospital admission to endocrine consult was 10.7 (SD 13.0) days. In the post-intervention period, we observed a 62% reduction in postoperative days in hyperglycaemia. The mean number of days between admission and endocrine consult was reduced by 6.3 days (59% reduction). CONCLUSIONS: Implementation of a simple, bedside algorithm for postoperative glucose monitoring and detection of hyperglycaemia in transplant patients, reduced the mean number of postoperative days in hyperglycaemia and time to inpatient endocrine consultation. Our algorithm continues to be used in our academic transplant unit. BMJ Publishing Group 2022-05-16 /pmc/articles/PMC9115008/ /pubmed/35577401 http://dx.doi.org/10.1136/bmjoq-2021-001796 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Quality Improvement Report
Clemens, Kristin K
Brahmania, Mayur
Weernink, Corrine
Lofty, Khaled
Rjoob, Hani
Berberich, Amanda
Gob, Alan
Reducing hyperglycaemia post-kidney and liver transplant: a quality improvement initiative
title Reducing hyperglycaemia post-kidney and liver transplant: a quality improvement initiative
title_full Reducing hyperglycaemia post-kidney and liver transplant: a quality improvement initiative
title_fullStr Reducing hyperglycaemia post-kidney and liver transplant: a quality improvement initiative
title_full_unstemmed Reducing hyperglycaemia post-kidney and liver transplant: a quality improvement initiative
title_short Reducing hyperglycaemia post-kidney and liver transplant: a quality improvement initiative
title_sort reducing hyperglycaemia post-kidney and liver transplant: a quality improvement initiative
topic Quality Improvement Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115008/
https://www.ncbi.nlm.nih.gov/pubmed/35577401
http://dx.doi.org/10.1136/bmjoq-2021-001796
work_keys_str_mv AT clemenskristink reducinghyperglycaemiapostkidneyandlivertransplantaqualityimprovementinitiative
AT brahmaniamayur reducinghyperglycaemiapostkidneyandlivertransplantaqualityimprovementinitiative
AT weerninkcorrine reducinghyperglycaemiapostkidneyandlivertransplantaqualityimprovementinitiative
AT loftykhaled reducinghyperglycaemiapostkidneyandlivertransplantaqualityimprovementinitiative
AT rjoobhani reducinghyperglycaemiapostkidneyandlivertransplantaqualityimprovementinitiative
AT berberichamanda reducinghyperglycaemiapostkidneyandlivertransplantaqualityimprovementinitiative
AT gobalan reducinghyperglycaemiapostkidneyandlivertransplantaqualityimprovementinitiative